Cargando…
Pathogenesis of Mucopolysaccharidoses, an Update
The recent advancements in the knowledge of lysosomal biology and function have translated into an improved understanding of the pathophysiology of mucopolysaccharidoses (MPSs). The concept that MPS manifestations are direct consequences of lysosomal engorgement with undegraded glycosaminoglycans (G...
Autores principales: | Fecarotta, Simona, Tarallo, Antonietta, Damiano, Carla, Minopoli, Nadia, Parenti, Giancarlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178160/ https://www.ncbi.nlm.nih.gov/pubmed/32260444 http://dx.doi.org/10.3390/ijms21072515 |
Ejemplares similares
-
New treatments for the mucopolysaccharidoses: from pathophysiology to therapy
por: Fecarotta, Simona, et al.
Publicado: (2018) -
Epidemiology of Mucopolysaccharidoses Update
por: Celik, Betul, et al.
Publicado: (2021) -
Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
por: Tarallo, Antonietta, et al.
Publicado: (2021) -
Carnitine is a pharmacological allosteric chaperone of the human lysosomal α-glucosidase
por: Iacono, Roberta, et al.
Publicado: (2021) -
Diagnosis of Mucopolysaccharidoses
por: Kubaski, Francyne, et al.
Publicado: (2020)